Krishna Institute of Medical Sciences Ltd (KIMS) posted a consolidated net profit of Rs 669 million for the September 2025 quarter, supported by strong operational revenue of Rs 9.61 billion. The results reflect continued growth in patient volumes, service diversification, and regional expansion across its hospital network.
Steady Growth Momentum Continues In Q2 FY2025–26
Krishna Institute of Medical Sciences Ltd, one of India’s leading multi-specialty healthcare providers, has announced its financial results for the quarter ended September 30, 2025. The company reported consolidated revenue from operations of Rs 9.61 billion and a net profit of Rs 669 million, underscoring its operational resilience and strategic execution.
The robust performance was driven by higher occupancy rates, increased surgical volumes, and the addition of new specialties across its network of hospitals in Telangana, Andhra Pradesh, and Maharashtra. KIMS also benefited from improved cost efficiencies and digital health initiatives that enhanced patient engagement and clinical outcomes.
Management reaffirmed its focus on expanding into underserved markets, investing in medical infrastructure, and enhancing clinical capabilities to sustain long-term growth.
Key Highlights
-
Q2 FY2025–26 consolidated revenue: Rs 9.61 billion
-
Net profit for the quarter: Rs 669 million
-
Growth supported by higher patient volumes and service expansion
-
Operational efficiencies and digital initiatives boosted margins
-
Continued focus on regional expansion and specialty care
Sources: BSE Filings, Economic Times, Business Standard, Krishna Institute of Medical Sciences Ltd Investor Updates